PTGS1 and acute coronary syndrome: It has been reported that doses of aspirin as low as 30 mg/day for a week could completely block the effects of COX-1 (17), and the effective aspirin dose ranges between 50 and 100 mg/day based on randomized controlled trials in both acute coronary syndrome and stable patients with CVD (18).